Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05034 | 33400402 | J Cell Mol Med | Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation. | 2021 | Details |
| A05035 | 33399334 | Nurse Pract | Dietary approaches to managing nonalcoholic fatty liver disease. | 2021 | Details |
| A05036 | 33399331 | J Pediatr Gastroenterol Nutr | Dairy Fat Intake, Plasma Pentadecanoic Acid, and Plasma Iso-heptadecanoic Acid Are Inversely Associated With Liver Fat in Children. | 2021 | Details |
| A05037 | 33398776 | Hepatol Int | Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice. | 2021 | Details |
| A05038 | 33398223 | J Clin Exp Hepatol | Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? | 2020 | Details |
| A05039 | 33397952 | Nat Commun | Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH. | 2021 | Details |
| A05040 | 33397443 | Biol Sex Differ | Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. | 2021 | Details |
| A05041 | 33397230 | Curr Pharm Des | Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease. | 2021 | Details |
| A05042 | 33396949 | Metabolites | Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2020 | Details |
| A05043 | 33396939 | Int J Mol Sci | Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding. | 2020 | Details |
| A05044 | 33396535 | Int J Mol Sci | Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. | 2020 | Details |
| A05045 | 33396456 | Antioxidants (Basel) | Antioxidant and Hypolipidemic Activity of Açai Fruit Makes It a Valuable Functional Food. | 2020 | Details |
| A05046 | 33395640 | Georgian Med News | [PROGNOSIS ASSESSMENT OF THE COMBINED COURSE OF STABLE CORONARY HEART DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS AFTER REVASCULARIZATION INTERVENTIONS]. | 2020 | Details |
| A05047 | 33395434 | PLoS One | Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales. | 2021 | Details |
| A05048 | 33395403 | Am J Case Rep | A Case of Hypopituitarism Complicated by Non-Alcoholic Steatohepatitis and Severe Pulmonary Hypertension. | 2021 | Details |
| A05049 | 33394807 | Eur J Gastroenterol Hepatol | The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. | 2021 | Details |
| A05050 | 33394549 | Diabetes Obes Metab | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes. | 2021 | Details |
| A05051 | 33393329 | Rev Esp Enferm Dig | Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection. | 2021 | Details |
| A05052 | 33392801 | Curr Atheroscler Rep | Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel? | 2021 | Details |
| A05053 | 33392241 | Front Nutr | The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)-A Systematic Review and Meta-Analysis. | 2020 | Details |
| A05054 | 33392234 | Front Med (Lausanne) | Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease. | 2020 | Details |
| A05055 | 33392221 | Front Med (Lausanne) | Pre-transplant Sarcopenic Obesity Worsens the Survival After Liver Transplantation: A Meta-Analysis and a Systematic Review. | 2020 | Details |
| A05056 | 33391955 | Cureus | Non-alcoholic Fatty Liver Disease Causing Platypnea-Orthodeoxia Syndrome. | 2020 | Details |
| A05057 | 33391484 | Theranostics | Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice. | 2021 | Details |
| A05058 | 33391254 | Front Immunol | A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model. | 2020 | Details |
| A05059 | 33391181 | Front Endocrinol (Lausanne) | Identification of the Biomarkers and Pathological Process of Heterotopic Ossification: Weighted Gene Co-Expression Network Analysis. | 2020 | Details |
| A05060 | 33390979 | Front Pharmacol | Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate. | 2020 | Details |
| A05061 | 33390956 | Front Pharmacol | Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway. | 2020 | Details |
| A05062 | 33390939 | Front Pharmacol | Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice. | 2020 | Details |
| A05063 | 33390768 | Int J Med Sci | Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function. | 2021 | Details |
| A05064 | 33390398 | J Nutr Sci Vitaminol (Tokyo) | Gene Expression and Histochemical Analyses in the Fatty Livers of Rats Fed a Histidine-Excess Diet. | 2020 | Details |
| A05065 | 33389543 | Rev Endocr Metab Disord | Lean NAFLD: an underrecognized and challenging disorder in medicine. | 2021 | Details |
| A05066 | 33389416 | Dig Dis Sci | A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05067 | 33388954 | Pediatr Surg Int | The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model. | 2021 | Details |
| A05068 | 33388736 | Orv Hetil | Sarcopenia - 2021: Pathophysiology, diagnosis, therapy | 2021 | Details |
| A05069 | 33388475 | Prostaglandins Leukot Essent Fatty Acids | Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease. | 2020 | Details |
| A05070 | 33388433 | Free Radic Biol Med | Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress. | 2021 | Details |
| A05071 | 33388173 | Clin Ther | The Role of Advanced Practice Providers in the Care of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05072 | 33387670 | Clin Gastroenterol Hepatol | The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants. | 2020 | Details |
| A05073 | 33387664 | Mitochondrion | Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A05074 | 33387126 | Dig Dis Sci | Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis. | 2021 | Details |
| A05075 | 33386676 | Liver Int | Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. | 2021 | Details |
| A05079 | 33385408 | Life Sci | Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease. | 2020 | Details |
| A05080 | 33385317 | J Dig Dis | Efficacy and safety of drugs for nonalcoholic steatohepatitis. | 2021 | Details |
| A05081 | 33384662 | Front Endocrinol (Lausanne) | Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies. | 2020 | Details |
| A05082 | 33384553 | World J Gastroenterol | Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. | 2020 | Details |
| A05083 | 33384552 | World J Gastroenterol | Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study. | 2020 | Details |
| A05084 | 33383965 | J Clin Med | The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05085 | 33383448 | Int Immunopharmacol | Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. | 2020 | Details |
| A05086 | 33383173 | Mol Metab | FGF19 and FGF21: In NASH we trust. | 2020 | Details |
| A05087 | 33382757 | PLoS One | Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. | 2020 | Details |
| A05088 | 33382431 | J Nutr | Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. | 2021 | Details |
| A05089 | 33381794 | Am J Clin Nutr | Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial. | 2021 | Details |
| A05090 | 33381677 | Curr Dev Nutr | Impact of the Analytical Approach on the Reliability of MRI-Based Assessment of Hepatic Fat Content. | 2020 | Details |
| A05091 | 33381084 | Front Endocrinol (Lausanne) | FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases. | 2020 | Details |
| A05092 | 33379253 | Nutrients | Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial. | 2020 | Details |
| A05093 | 33379170 | Molecules | Synthesis, Photoisomerization, Antioxidant Activity, and Lipid-Lowering Effect of Ferulic Acid and Feruloyl Amides. | 2020 | Details |
| A05094 | 33378966 | Biomed Pharmacother | Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. | 2020 | Details |
| A05095 | 33378413 | PLoS One | A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. | 2020 | Details |
| A05096 | 33378048 | Eur Rev Med Pharmacol Sci | Gut microbiota and its metabolic potential. | 2020 | Details |
| A05097 | 33377363 | Asia Pac J Clin Nutr | Efficacy of ursodeoxycholic acid in nonalcoholic fatty liver disease: An updated meta-analysis of randomized controlled trials. | 2020 | Details |
| A05098 | 33377125 | Cell Rep Med | Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes. | 2020 | Details |
| A05099 | 33377114 | STAR Protoc | Isolation, culture, and functional analysis of hepatocytes from mice with fatty liver disease. | 2020 | Details |
| A05100 | 33376713 | Can J Gastroenterol Hepatol | The Clinical Significance of Colon Polyp Pathology in Nonalcoholic Fatty Liver Disease (NAFLD) and Its Impact on Screening Colonoscopy in Daily Practice. | 2020 | Details |
| A05101 | 33376374 | Diabetes Metab Syndr Obes | The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05102 | 33376110 | BMJ Open Gastroenterol | Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. | 2020 | Details |
| A05103 | 33375190 | Int J Mol Sci | Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. | 2020 | Details |
| A05104 | 33374984 | Molecules | Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells. | 2020 | Details |
| A05105 | 33374554 | Nutrients | Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05106 | 33374435 | J Clin Med | In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. | 2020 | Details |
| A05107 | 33373666 | Diabetes Metab | Dose-response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease. | 2020 | Details |
| A05108 | 33373113 | Liver Int | The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. | 2021 | Details |
| A05109 | 33372630 | Cell Biosci | Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. | 2020 | Details |
| A05110 | 33372390 | J Diabetes Investig | Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta-analysis of observational studies. | 2021 | Details |
| A05111 | 33372064 | Biol Open | A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference. | 2021 | Details |
| A05112 | 33371482 | Biomolecules | Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. | 2020 | Details |
| A05113 | 33371282 | Int J Environ Res Public Health | The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES). | 2020 | Details |
| A05114 | 33371031 | BMJ Open | Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study. | 2020 | Details |
| A05115 | 33370951 | BMJ Case Rep | Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed. | 2020 | Details |
| A05116 | 33370454 | J Gastroenterol Hepatol | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes. | 2021 | Details |
| A05117 | 33369880 | Liver Int | Ramadan fasting and liver diseases: A review with practice advices and recommendations. | 2021 | Details |
| A05118 | 33369197 | Mol Nutr Food Res | Punicalagin Prevents Hepatic Steatosis through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet-Fed Mice. | 2021 | Details |
| A05119 | 33368954 | Diabetes Obes Metab | Pioglitazone and bariatric surgery are the most effective treatments for non-alcoholic steatohepatitis: A hierarchical network meta-analysis. | 2021 | Details |
| A05120 | 33368494 | J Clin Periodontol | Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults. | 2021 | Details |
| A05121 | 33365321 | Front Med (Lausanne) | Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study. | 2020 | Details |
| A05122 | 33365151 | J Ultrason | Shear wave elastography reveals a high prevalence of liver fibrosis in overweight or obese Hispanic youth. | 2020 | Details |
| A05123 | 33364879 | Sisli Etfal Hastan Tip Bul | The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients. | 2020 | Details |
| A05124 | 33363621 | Oncol Lett | Biological effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and anti-neoplasic natural compound. | 2020 | Details |
| A05125 | 33363517 | Front Endocrinol (Lausanne) | The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor. | 2020 | Details |
| A05126 | 33363258 | JGH Open | Association of metabolic-associated fatty liver disease and risk of severe coronavirus disease 2019 illness. | 2020 | Details |
| A05127 | 33363067 | Front Pediatr | New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. | 2020 | Details |
| A05128 | 33363046 | Front Cell Infect Microbiol | E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization. | 2020 | Details |
| A05129 | 33362721 | Front Endocrinol (Lausanne) | Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05130 | 33362390 | World J Gastroenterol | Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. | 2020 | Details |
| A05131 | 33362385 | World J Gastroenterol | Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats. | 2020 | Details |
| A05132 | 33361718 | Malays J Pathol | Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373. | 2020 | Details |
| A05133 | 33361348 | Gut | RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05134 | 33360580 | Environ Pollut | Exposure to nitenpyram during pregnancy causes colonic mucosal damage and non-alcoholic steatohepatitis in mouse offspring: The role of gut microbiota. | 2020 | Details |
| A05136 | 33359683 | Free Radic Biol Med | ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice. | 2020 | Details |
| A05137 | 33359401 | Mol Metab | Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. | 2020 | Details |